Livzon Pharmaceutical Group Inc.
1513Pharmaceuticals
HK$22.22+0.63%As of Oct 29vs prior close
- Market cap
- $849M
- P/E (TTM)
- 3.6×
- P/E (FY1)
- 9.0×
- From 52W high
- −1.94%
- EPS (TTM)
- –
- Revenue (LTM)
- CN¥10.2B
- Net margin
- 15.23%
- Dividend yield
- –
Nomior Score
58
Patient ValueTop 32% of the scored universe
Growth47
Quality55
Value67
Momentum—
Resilience57
Growth
−1.63%revenue a year over 3 fiscal years
YE22 CN¥12.6BLTM CN¥10.2B
Connections
Revenue to profitYE25
17% of revenue became net profit, down 1 pt on a year.